Close Menu

Getting to the Clinic

Technology Review takes a look at Nanosphere's Verigene, a tool that uses both microfluidics and nanotechnology to screen DNA from a blood sample. "We believe the benefit of our system is that this simple cartridge format could be run in any hospital, even a doctor's office," the company's chief executive says. "We're moving complex testing to the point of patient care." Instead of testing taking days, Nanosphere is developing their product to do so in an hour or two.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.